Nian Sun

Nian Sun

Auto-generated profile, based on publicly available information

Nian Sun

Department of Otolaryngology, Head and Surgery, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2015 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
PZPeng Zhang
Peng Zhang
JYJingying Ye
Jingying Ye
CPChuxiong Pan
Chuxiong Pan
NSNian Sun
Nian Sun
DKDan Kang
Dan Kang

9 June 2024 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
XLXiaodan Li
Xiaodan Li
GZGe Zhang
Ge Zhang
YLYanzhen Li
Yanzhen Li
XZXuexi Zhang
Xuexi Zhang
QLQiaoyin Liu
Qiaoyin Liu
XNXin Ni
Xin Ni
Objectives: The study aims to retrospectively summarize the clinical features of pediatric thyroglossal duct cyst (TGDC), investigate the efficacy of the modified Sistrunk (mSis) procedure, and analyze the recurrence risks. Methods: The clinical data of 391 children with TGDC admitted to Beijing Children’s Hospital affiliated Capital Medical University and Baoding Children’s Hospital from March 2012 to December 2021 were retrospectively analyzed. All patients underwent cervical ultrasound for preoperative evaluation. Twenty cases had magnetic resonance imaging and 8 cases had computed tomography for further evaluation. All patients underwent the standard mSis procedure, and clinical manifestations information, surgical information, complications, and prognosis were analyzed. Results: Among the 391 TGDC cases, 118 (30.2%) had a history of recurrent neck infection and 36 (9.2%) had undergone previous neck cyst and fistula resection surgeries, initially diagnosed as neck cyst (22 cases), TGDC (12 cases), or branchial fistula (2 cases), with only 6 cases having undergone partial hyoid bone resection in the previous operation. During the 15 to 156 months of follow-up, 10 children experienced local wound infection, but no other complications were reported. The recurrence rate was 2.30%, and the recurrence time ranged from 0.5 to 34 (average, 7.2) months post surgery. In the Poisson regression model examining factors related to recurrence, the P values of the 3 factors were <.05: clearness of the lesion boundary, surgical history, and maximum diameter and the relative risk (RR) values corresponding to the 3 risk factors, such as Exp (B), were 27.918, 10.054, and 6.606, respectively. Conclusions: The mSis procedure demonstrated safety and efficacy with fewer complications and a low recurrence rate of 2.30% in the study. Furthermore, the indistinct lesion boundary, surgical history, and large lesion diameter (>2 cm) were independent risk factors for recurrence in pediatric TGDC. Level of Evidence: IV

25 January 2021 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
YLYanzhen Li
Yanzhen Li
SWShengcai Wang
Shengcai Wang
JTJun Tai
Jun Tai
JZJie Zhang
Jie Zhang
LHLejian He
Lejian He
XNXin Ni
Xin Ni
Objectives: Bronchogenic cyst is a rare congenital disease which occurs especially in the neck region. This report presents 6 cases of bronchogenic cysts and discusses the diagnosis and surgical experience of this anomaly. Methods: A retrospective study of 6 pediatric patients with cervical bronchogenic cysts treated in our hospital during 2016 to 2019 was performed. We recorded and analyzed the clinical data of the patients, including age, symptoms, imaging findings, surgical procedure, and complications. Results: All patients underwent surgical excision. The chondroid tissues were found at the base of cysts which clung to the trachea in 5 patients and completely removed by surgery without recurrence. One patient showed recurrence due to residual cartilage after the first surgery, and the second surgery was required to resect the remaining cartilage. During the surgery, the recurrent laryngeal nerve (RLN) detector was used, which confirmed that all the RLNs clung to the side wall of cysts. All cases were cured without complications. Conclusions: Although rare, bronchogenic cysts should be considered in the differential diagnosis of peritracheal masses in children. Complete resection of the bronchogenic cysts, including the cartilages at the base, is vital in preventing recurrence. The RLN must be protected during the surgery.

8 November 2024 in Cancer Research
Verified
Journal Article
Open access
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
The dynamic interplay between tumor cells and γδT cells within the tumor microenvironment significantly influences disease progression and immunotherapy outcome. In this study, we delved into the modulation of γδT-cell activation by tumor cell ligands CD112 and CD155, which interact with the activating receptor DNAM-1 on γδT cells. Spatial and single-cell RNA sequencing, as well as spatial metabolomic analysis, from neuroblastoma revealed that the expression levels and localization of CD112 and CD155 varied across and within tumors, correlating with differentiation status, metabolic pathways, and ultimately disease prognosis and patient survival. Both in vivo tumor xenograft experiments and in vitro coculture experiments demonstrated that a high CD112/CD155 expression ratio in tumors enhanced γδT cell–mediated cytotoxicity, whereas a low ratio fostered tumor resistance. Mechanistically, CD112 sustained DNAM-1–mediated γδT-cell activation, whereas CD155 downregulated DNAM-1 expression via E3 ubiquitin ligase tripartite motif–containing 21–mediated ubiquitin proteasomal degradation. By interacting with tumor cells differentially expressing CD112 and CD155, intratumoral γδT cells exhibited varying degrees of activation and DNAM-1 expression, representing three major functional subsets. This study underscores the complexity of tumor–immune cross-talk, offering insights into how tumor heterogeneity shapes the immune landscape. Significance: Tumor cells in different intratumoral neighborhoods display divergent patterns of ligands that regulate γδT-cell activation, highlighting multilevel regulation of antitumor immunity resulting from the heterogeneity of intercellular interactions in the tumor microenvironment.

11 June 2020 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
NSNian Sun
Nian Sun
JYJingying Ye
Jingying Ye
JZJunbo Zhang
Junbo Zhang
DKDan Kang
Dan Kang
JTJun Tai
Jun Tai
XNXin Ni
Xin Ni
Positional obstructive sleep apnea hypopnea syndrome (P-OSAHS) is a distinct OSAHS type. Whether velopharyngeal surgery is efficacious for patients with P-OSAHS remains unclear. To investigate the efficacy and factors influencing velopharyngeal surgery for treatment of patients with P-OSAHS, defined as the apnea hypopnea index (AHI) in different body postures (supine AHI ≥2*nonsupine AHI). A total of 44 patients with P-OSAHS who underwent velopharyngeal surgery were retrospectively studied. The clinical data of these patients, including polysomnography (PSG), physical examination, and surgical information, were collected for analysis. All patients underwent a PSG about 6 months after surgery to determine the treatment outcomes. The overall AHI of the 44 patients decreased from 40.2 ± 18.7 events/h to 18.5 ± 17.5 events/h after surgery (P < .001). There were 29 responders (65.9%) according to the classical definition of surgical success. The percentage of sleep time with oxygen saturation below 90% (CT90) was the only predictive parameter for surgical success (P = .014, odds ratio value = 0.894). There was no significant difference between the change in supine AHI (−55.9 ± 35.2%) and the change in nonsupine AHI (−43.4 ± 74.1%; P = .167), and these 2 parameters were significantly correlated (r = 0.616, P < .001). Among the 38 patients with residual OSAHS (residual AHI ≥5), 28 had persistent P-OSAHS, and the percentage was as high as 82.4%. Patients with P-OSAHS with a lower CT90 value are more likely to benefit from velopharyngeal surgery. Positional therapy could be indicated for most of the patients who are not cured by such surgery.

17 June 2026
Verified
Other
Open access
XWXiaolin Wang
Xiaolin Wang
HWHui Wang
Hui Wang
ZLZhengjing Lu
Zhengjing Lu
XLXiangjun Liu
Xiangjun Liu
WCWenjia Chai
Wenjia Chai
JGJingang Gui
Jingang Gui
Supplementary Figure 14 The effects of soluble CD155 or CD155 on NB cells on DNAM-1, PD-1, TIM-3 and TIGIT expression levels in γδT cells during the interaction with NB microenvironment. (A-C) α-CD155 is used in the co-culture of γδT cells and SH-SY5Y cells. DNAM-1, PD-1, TIM-3 and TIGIT are detected by FACS after 24 h co-culture (left) and MFI is labeled in the representative FACS histograms (right). (D-G) α-CD155 is used in the co-culture of γδT cells and primary NB tumor cells. DNAM-1, PD-1, TIM-3 and TIGIT expression are detected by FACS after 24 h co-culture (left) and MFI is labeled in the representative FACS histograms (right). (H-K) DNAM-1, PD-1, TIM-3 and TIGIT expression are detected by FACS after 24 h NB TTCS treatment (left) and MFI is labeled in the representative FACS histograms (right). The results are expressed as the means ± SEMs from at least three independent experiments. Significant differences between groups are represented by ns no significance, * p < 0.05 and ** p < 0.01.